FRIDAY, Oct. 29, 2021 (HealthDay News) — Coronavirus cases have plunged by 60% since mid-September’s Delta-driven peak, U.S. health officials said earlier this week. But with winter on the way, they warned that Americans still need to protect themselves and others against COVID-19. “We are now heading in the rightContinue Reading

FRIDAY, Oct. 29, 2021 (HealthDay News) — There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new study shows. The findings could point to ways to help people with HIV keep the virus in remission without having to keepContinue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — ADHD medications are increasingly being prescribed to older adults, and they may cause a short-term spike in the risk of heart attack, stroke and arrhythmias, a large new study suggests. Stimulant medications, such as Ritalin, Concerta and Adderall, are commonly used to treatContinue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2Continue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated. But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reportsContinue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows. Researchers found that the shorter regimen — given over five weeks, instead of seven — did not raise patients’ odds of lasting side effects.Continue Reading